ResMed (RMD) Tops Q4 EPS by 7c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $225.16 +0.14%
Financial Fact:
Total other income, net: -1.22M
Today's EPS Names:
FWDI, GO, BATL, More
Financial Fact:
Total other income, net: -1.22M
Today's EPS Names:
FWDI, GO, BATL, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $2.55, $0.07 better than the analyst estimate of $2.48. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.33 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Google execs convened 'all-hands' meeting last week to address AI unit reorganizations amid staff concerns - Reuters
- U.S. power output rises 7% in week ended August 8
- Ship traffic through Strait of Hormuz near three-month low
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
